Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

46.74
+0.60001.30%
Post-market: 46.810.0700+0.15%19:59 EDT
Volume:10.91M
Turnover:511.14M
Market Cap:206.73B
PE:11.68
High:47.17
Open:46.35
Low:46.34
Close:46.14
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:0.82
T/O Rate:0.34%
Dividend:1.72
Dividend Rate:3.68%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.35
PE(LYR):12.91

Loading ...

Novo Nordisk’s AMAZE 13 Trial Adds Fresh Momentum to Its Obesity Pipeline

TIPRANKS
·
Jul 22

Top Midday Stories: 3M Shares Rise on Strong Guidance; Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising

MT Newswires Live
·
Jul 21

Eli Lilly on Novo Nordisk Lawsuit- "we Stand Firmly Behind Our Advertising"

THOMSON REUTERS
·
Jul 21

Eli Lilly Faces Lawsuit Over Weight-Loss Drug Ads! Accused By Novo Nordisk Of "Misleading Marketing"

Sector Pulse
·
Jul 21

U.S. Stocks on the Move-utz Brands, Tutor Perini, Tripadvisor

Reuters
·
Jul 21

Novo Nordisk Shares Dip 2% in Pre-Market Trading

Deep News
·
Jul 21

Novo Nordisk Shares Down 2% After Co Sues Lilly, Accusing it of False Advertising

THOMSON REUTERS
·
Jul 21

Eli Lilly Faces Legal Action from Novo Nordisk Over Alleged Misleading Weight-Loss Drug Advertisements

Stock News
·
Jul 21

Novo Nordisk Says Mismatched Diabetes Drug Ads Triggered Lawsuit Vs. Lilly

Dow Jones
·
Jul 21

Novo Nordisk files lawsuit against ‘misleading’ GLP-1 ads from Eli Lilly

TIPRANKS
·
Jul 21

Novo Nordisk Sues Eli Lilly Over Zepbound, Mounjaro Advertising

MT Newswires Live
·
Jul 21

Novo Nordisk Sues Eli Lilly Over Allegedly Misleading GLP-1 Advertising

MT Newswires Live
·
Jul 21

Novo Nordisk Sues Eli Lilly in U.S. Federal Court, Alleging Claim Under the Lanham Act, Court Records Show

THOMSON REUTERS
·
Jul 21

The world is desperate for weight-loss drugs. But Big Pharma can’t advertise them

CNN Business
·
Jul 21

Novo Nordisk price target raised to DKK 330 from DKK 290 at Citi

TIPRANKS
·
Jul 21

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 21

Update: Novo Nordisk's Wegovy Approved in India for Fatty Liver Disease Treatment

MT Newswires Live
·
Jul 20

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

TIPRANKS
·
Jul 20

Novo Nordisk Guidance in Focus

Dow Jones
·
Jul 20

Trump's FDA May Soon Back Peptides. Should You Buy In?

Dow Jones
·
Jul 18